<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=S-18986</id>
	<title>S-18986 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=S-18986"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=S-18986&amp;action=history"/>
	<updated>2026-07-19T22:41:23Z</updated>
	<subtitle>本wiki上该页面的版本历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=S-18986&amp;diff=3951498&amp;oldid=prev</id>
		<title>2024年4月2日 (二) 03:54 imported&gt;CYCcc</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=S-18986&amp;diff=3951498&amp;oldid=prev"/>
		<updated>2024-04-02T03:54:32Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{medical}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 451559889&lt;br /&gt;
| IUPAC_name = (&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide&lt;br /&gt;
| image = S-18986.svg&lt;br /&gt;
| width = 200px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A, B1, B2, B3, C, D, X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A, B, C, D, X --&amp;gt;&lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled, S2, S3, S4, S5, S6, S7, S8, S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = Investigational New Drug&lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| protein_bound =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| IUPHAR_ligand = 4304&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CAS_number = 175340-20-2 &lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = IA262432Y9 &lt;br /&gt;
| ATC_prefix =  &lt;br /&gt;
| ATC_suffix =  &lt;br /&gt;
| PubChem = 637863&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}&lt;br /&gt;
| ChemSpiderID = 553445&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=10 | H=12 | N=2 | O=2 | S=1 &lt;br /&gt;
| smiles = C1C[C@@H]2NS(=O)(=O)C3=CC=CC=C3N2C1&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C10H12N2O2S/c13-15(14)9-5-2-1-4-8(9)12-7-3-6-10(12)11-15/h1-2,4-5,10-11H,3,6-7H2/t10-/m1/s1&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChIKey = MNTIJYGEITVWHU-SNVBAGLBSA-N&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;S-18986&amp;#039;&amp;#039;&amp;#039;，是一种与环噻嗪相关的[[AMPA受体]][[正变构调节剂]]。动物研究發現S-18986有[[益智藥|促智]]和[[神经保护]]的作用，另外這種物質能誘導大脑[[海马体|海馬體]]及[[額葉|额叶皮层]]中[[脑源性神经营养因子]]和&amp;#039;&amp;#039;&amp;#039;[[AMPA|α-氨基-3-羥基-5-甲基-4-異惡唑丙酸]]&amp;#039;&amp;#039;&amp;#039;（AMPA）介导[[去甲肾上腺素]]及[[乙酰胆碱]]释放。&amp;lt;ref name=&amp;quot;pmid10924919&amp;quot;&amp;gt;{{Cite journal|title=(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices|date=August 2000|journal=European Journal of Pharmacology|issue=2|doi=10.1016/S0014-2999(00)00433-7|volume=401|pages=145–53|pmid=10924919}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid10924928&amp;quot;&amp;gt;{{Cite journal|title=Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats|date=August 2000|journal=European Journal of Pharmacology|issue=2|doi=10.1016/S0014-2999(00)00429-5|volume=401|pages=205–12|pmid=10924928}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid12706264&amp;quot;&amp;gt;{{Cite journal|title=Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain|date=April 2003|journal=Brain Research|issue=1–2|doi=10.1016/S0006-8993(03)02357-6|volume=970|pages=221–5|pmid=12706264}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid15135908&amp;quot;&amp;gt;{{Cite journal|title=S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat|date=May 2004|journal=Neuroscience Letters|issue=1–3|doi=10.1016/j.neulet.2003.12.061|volume=361|pages=120–3|pmid=15135908}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid15860654&amp;quot;&amp;gt;{{Cite journal|title=Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat|date=August 2005|journal=Drug Metabolism and Disposition|issue=8|doi=10.1124/dmd.105.004424|volume=33|pages=1137–43|pmid=15860654}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid17384936&amp;quot;&amp;gt;{{Cite journal|title=Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil|url=https://archive.org/details/sim_psychopharmacology_2007-07_193_1/page/63|date=July 2007|journal=Psychopharmacology|issue=1|doi=10.1007/s00213-007-0765-4|volume=193|pages=63–73|pmid=17384936}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid18469541&amp;quot;&amp;gt;{{Cite journal|title=The AMPA modulator S 18986 improves declarative and working memory performances in aged mice|date=May 2008|journal=Behavioural Pharmacology|issue=3|doi=10.1097/FBP.0b013e3282feb0c1|volume=19|pages=235–44|pmid=18469541}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid18762915&amp;quot;&amp;gt;{{Cite journal|title=Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats|date=January 2009|journal=Psychopharmacology|issue=1–3|doi=10.1007/s00213-008-1301-x|volume=202|pages=225–35|pmid=18762915}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid19136940&amp;quot;&amp;gt;{{Cite journal|title=GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986|date=April 2009|journal=Cell Death and Differentiation|issue=4|doi=10.1038/cdd.2008.188|volume=16|pages=624–37|pmid=19136940}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid19501111&amp;quot;&amp;gt;{{Cite journal|title=The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis|date=September 2009|journal=Neuropharmacology|issue=3|doi=10.1016/j.neuropharm.2009.05.010|volume=57|pages=277–86|pmid=19501111}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 參見 ==&lt;br /&gt;
&lt;br /&gt;
* [[AMPA受體正變構調節劑]]&lt;br /&gt;
&lt;br /&gt;
== 参考文獻 ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
[[Category:试验药物]]&lt;/div&gt;</summary>
		<author><name>imported&gt;CYCcc</name></author>
	</entry>
</feed>